News
03-04-2013, 03:20 AM
A groundbreaking new study led by the University of Kentucky Markey Cancer Center's Dr. Peter Zhou found that triple-negative breast cancer cells are missing a key enzyme that other cancer cells contain - providing insight into potential therapeutic targets to treat the aggressive cancer...
More... (http://www.medicalnewstoday.com/releases/257094.php)
More... (http://www.medicalnewstoday.com/releases/257094.php)